The impact of antiviral therapy on hepatocellular carcinoma epidemiology

The development of nucleos(t)ide analogs and direct antiviral agents has revolutionized the management of chronic infection with HBV and HCV, respectively. These regimens allow to expand treatment to virtually all infected, including those with poor hepatic reserve and those with severe comorbiditie...

書目詳細資料
發表在:	Hepatic Oncology
Main Authors:	Massimo Colombo, Ana Lleo
格式:	Article
語言:	英语
出版:	Taylor & Francis 2018-01-01
主題:	direct-acting antivirals HBV HCV hepatocellular carcinoma nucleos(t)ide analogs
在線閱讀:	https://www.futuremedicine.com/doi/10.2217/hep-2017-0024

相似書籍

Circulating thrombospondin 2 as a predictor of hepatocellular carcinoma in hepatitis B patients undergoing nucleos(t)ide analog therapy
由: Taiki Okumura, et al.
出版: (2024-10-01)

Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy
由: Chih-Lin Lin, et al.
出版: (2020-10-01)

Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic Review
由: Lorenzo Lani, et al.
出版: (2024-02-01)

HBV and HCV Therapy
由: Massimo Colombo, et al.
出版: (2009-10-01)

Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment
由: Sona Sargsyan, et al.
出版: (2024-05-01)

Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
由: El-Araby Mohamed Ibrahim Shalaby, et al.
出版: (2023-06-01)

Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies
由: Yi-Tse Su, et al.
出版: (2022-08-01)

Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
由: Sara Kishta, et al.
出版: (2020-06-01)

Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
由: Soo Ki Kim, et al.
出版: (2022-08-01)

Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
由: Soo Ryang Kim, et al.
出版: (2023-10-01)

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy
由: Honglian Gui, et al.
出版: (2021-08-01)

Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma
由: Shou-Wu Lee, et al.
出版: (2022-10-01)

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
由: Haohao Lu, et al.
出版: (2023-03-01)

Hepatitis B virus associated cirrhosis: overview of prognostic and management
由: Marilena Stoian
出版: (2023-06-01)

Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas
由: Wei Y, et al.
出版: (2019-09-01)

Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B
由: Hao-Che Chang, et al.
出版: (2024-02-01)

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
由: El Kassas M, et al.
出版: (2019-11-01)

Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase: Letter to the editor on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
由: Jian Wang, et al.
出版: (2025-04-01)

Prevention of Hepatitis B Vertical Transmission: Focus on Antenatal Antiviral Administration
由: Anandhara Indriani Khumaedi, et al.
出版: (2016-12-01)

Hepatocellular Carcinoma: from Hepatocyte to Liver Cancer Stem Cell
由: Ioannis eKarakasiliotis, et al.
出版: (2015-05-01)

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
由: Piero Colombatto, et al.
出版: (2022-03-01)

Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
由: Xinhui Wang, et al.
出版: (2020-03-01)

Long-term prediction of hepatocellular carcinoma using serum autotaxin levels after antiviral therapy for hepatitis C
由: Wataru Ando, et al.
出版: (2022-03-01)

Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
由: Mira Atef, et al.
出版: (2022-09-01)

Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies
由: Elisabetta Degasperi, et al.
出版: (2022-10-01)

Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
由: Cassia Leal, et al.
出版: (2023-01-01)

Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence
由: Ciro Celsa, et al.
出版: (2022-01-01)

Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis
由: Mingxing Xu, et al.
出版: (2019-03-01)

Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study
由: Mohamed Elgazzar, et al.
出版: (2024-05-01)

Chronic Hepatitis B In Elite Athletes
由: T. H. Nguyen, et al.
出版: (2025-03-01)

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
由: Jianming Yang, et al.
出版: (2023-01-01)

Chronic Hepatitis B Treatment: Current Perspectives on Telbivudine
由: Gian Paolo Caviglia, et al.
出版: (2017-12-01)

Sorafenib-treated hepatocellular carcinoma with or without prior direct-acting antiviral therapy for hepatitis C: outcomes and survival
由: Rania Lithy, et al.
出版: (2025-08-01)

Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis
由: Shi-Jia Liu, et al.
出版: (2025-02-01)

Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C
由: Naoki Kawagishi, et al.
出版: (2023-01-01)

Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
由: Dash S, et al.
出版: (2020-04-01)

Hepatocellular carcinoma with a direct right atrial extension in an HCV patient previously treated with direct-acting antiviral therapy: a case report
由: Mahmoud Abdelnabi, et al.
出版: (2019-09-01)

Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals: A Systematic Review and Meta-Analysis
由: Kristina Lindsley, et al.
出版: (2025-08-01)

Effect of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamideantiviral Therapy on Renal Function in Chronic Hepatitis B Patients: A Real-World Retrospective Study
由: Li Y, et al.
出版: (2025-02-01)

Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma
由: Jian Liu, et al.
出版: (2023-02-01)